- Home
- BZ vs GH Comparison
BZ vs GH Comparison
Compare BZ & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BZ
- GH
- Stock Information
- Founded
- BZ 2013
- GH 2011
- Country
- BZ China
- GH United States
- Employees
- BZ N/A
- GH N/A
- Industry
- BZ Computer Software: Programming Data Processing
- GH Medical Specialities
- Sector
- BZ Technology
- GH Health Care
- Exchange
- BZ Nasdaq
- GH Nasdaq
- Market Cap
- BZ 6.9B
- GH 6.1B
- IPO Year
- BZ 2021
- GH 2018
- Fundamental
- Price
- BZ $18.40
- GH $44.77
- Analyst Decision
- BZ Buy
- GH Strong Buy
- Analyst Count
- BZ 7
- GH 20
- Target Price
- BZ $20.00
- GH $48.40
- AVG Volume (30 Days)
- BZ 5.2M
- GH 2.4M
- Earning Date
- BZ 03-11-2025
- GH 02-20-2025
- Dividend Yield
- BZ N/A
- GH N/A
- EPS Growth
- BZ 42.62
- GH N/A
- EPS
- BZ 0.48
- GH N/A
- Revenue
- BZ $1,007,751,228.00
- GH $739,016,000.00
- Revenue This Year
- BZ $26.90
- GH $19.11
- Revenue Next Year
- BZ $12.13
- GH $21.44
- P/E Ratio
- BZ $36.52
- GH N/A
- Revenue Growth
- BZ 23.58
- GH 31.04
- 52 Week Low
- BZ $10.57
- GH $15.81
- 52 Week High
- BZ $22.74
- GH $50.89
- Technical
- Relative Strength Index (RSI)
- BZ 68.69
- GH 52.44
- Support Level
- BZ $17.00
- GH $34.88
- Resistance Level
- BZ $18.32
- GH $42.97
- Average True Range (ATR)
- BZ 0.78
- GH 3.27
- MACD
- BZ 0.19
- GH -0.29
- Stochastic Oscillator
- BZ 79.71
- GH 61.83
About BZ KANZHUN LIMITED American Depository Shares
Kanzhun's Boss Zhipin job platform connects job seekers and employers. Boss Zhipin is China's largest online recruitment platform based on average number of monthly active users, or MAU, and was established in 2014. Kanzhun earns revenue by providing services to enterprise customers primarily through its mobile app, which promotes engagement between recruiters and workers and operates on a recommendation basis powered by artificial intelligence. The platform specializes in transportation, logistics, construction, and service-based industries. About 85% of the companies looking to hire are small and medium-size enterprises. Its main competitors are 58.com, 51job, and Zhilian Zhaopin. Tencent has a 9.2% stake in Kanzhun.
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2022, the company launched a lab-developed test version of Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.